TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

First Page		Document Content
Health economics Healthcare quality Immunosuppressants Orphan drugs Costs Disease-modifying antirheumatic drug Tocilizumab Rituximab Quality-adjusted life year Rheumatoid arthritis Etanercept TNF inhibitor		TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS Add to Reading List Source URL: www.nicedsu.org.uk Download Document from Source Website File Size: 229,84 KB Share Document on Facebook

	Cost Effectiveness and Health Impact of Remediation Of Highly Polluted Sites in the Developing World May 2007 Authored by: David Hanrahan, Richard Fuller, Aadika Singh - Blacksmith Institute Reviewed by: DocID: 1rdHx - View Document
	Microsoft Word - valuing health DocID: 1qVy7 - View Document
	BRIEFING PAPER DEPARTMENT OF HEALTH PROPOSALS FOR INCLUDING BURDEN OF ILLNESS INTO VALUE BASED PRICING: A DESCRIPTION AND CRITIQUE DocID: 1qMvT - View Document
	The Economic Benefit of Pollution Clean-Up January 2010 BLACKSMITH INSTITUTE. Blacksmith Institute is a New York based organization formed in 1999 to remove the severe health risk posed to the worldʼs poor by pollution. DocID: 1qHim - View Document
	The social disvalue of premature deaths Hilary Greaves January 8, 2014 Biographical information: Hilary Greaves is Fellow and Tutor in Philosophy at Somerville College, Oxford. Her research interests include population e DocID: 1qDk8 - View Document